Patient Reported Outcomes in Primary Sclerosing Cholangitis: An Australian Perspective
Natassia Tan(The Alfred Hospital), Amanda Nicoll(The Royal Melbourne Hospital), Kate Collins(Austin Health), Nicholas Hannah(The Royal Melbourne Hospital), Kate D. Lynch(Royal Adelaide Hospital), Christopher Zampogna(Eastern Health), Rohit Sawhney(Eastern Health), John Lubel(Eastern Health), Siddharth Sood(The University of Melbourne), Andrew Coulshed(Royal Prince Alfred Hospital), Ammar Majeed(Monash University), Ken Liu, William Kemp(Monash University), Stuart K. Roberts(The Alfred Hospital), Stephen R. Bloom(Eastern Health), Avik Majumdar(The University of Melbourne)
Cited by 6
Related Papers
O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress
|Journal of Hepatology|2017|151
Obeticholic acid—a new therapy in PBC and NASH
|British Medical Bulletin|2020|123
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System
|Hepatology|2018|106
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
|Clinical Gastroenterology and Hepatology|2019|104
Utility of transient elastography in the non‐invasive evaluation of cystic fibrosis liver disease
|Liver International|2013|58